Cat. No.: OCKT-2603-CXX-031
Description: This product can be used to efficiently construct the human small-cell lung cancer organoid. Featuring a specialized basal medium and growth supplements, this product supports the robust in vitro modeling of human small-cell lung cancer.
Price: Inquiry
Datasheet: Datasheet
| Size | 100 mL/500 mL |
| Advantages | By faithfully simulating the small cell lung cancer microenvironment, these organoids facilitate the study of cancer cell dynamics. They are instrumental in tracking cellular responses to pharmaceutical agents and in assessing drug efficacy and safety profiles. |
| Species | Human |
| Components | Basal Medium A; Supplement B & Supplement C. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Basal Medium A: 4°C, 1 year; Supplement B & Supplement C: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Supplement B & Supplement C: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.
